Tizzani A - Search Results

1

Carcinogen-DNA adducts in bladder biopsies and urothelial cells: a risk assessment exercise.

Talaska G, Schamer M, Casetta G, Tizzani A, Vineis P. Talaska G, et al. Among authors: tizzani a. Cancer Lett. 1994 Aug 29;84(1):93-7. doi: 10.1016/0304-3835(94)90362-x. Cancer Lett. 1994. PMID: 8076366

2

Tobacco smoke, recurrences, and p53/bcl-2 expression in bladder cancer.

Pacchioni D, Martone T, Ghisolfi G, Bussolati G, Tizzani A, Casetta G, Vineis P. Pacchioni D, et al. Among authors: tizzani a. Carcinogenesis. 1997 Aug;18(8):1659-61. doi: 10.1093/carcin/18.8.1659. Carcinogenesis. 1997. PMID: 9276645

3

CA-50 as tumour marker in transitional bladder carcinoma.

Tizzani A, Casetta G, Piana P, Piantino P. Tizzani A, et al. Br J Urol. 1989 Jun;63(6):616-8. doi: 10.1111/j.1464-410x.1989.tb05256.x. Br J Urol. 1989. PMID: 2752254

4

Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers.

Sier CF, Casetta G, Verheijen JH, Tizzani A, Agape V, Kos J, Blasi F, Hanemaaijer R. Sier CF, et al. Among authors: tizzani a. Clin Cancer Res. 2000 Jun;6(6):2333-40. Clin Cancer Res. 2000. PMID: 10873084

5

Urinary evaluation of tumor-associated antigens in urothelial bladder tumors.

Piana P, Casetta G, Cavallini A, Piantino P, Tizzani A. Piana P, et al. Among authors: tizzani a. Prog Clin Biol Res. 1991;370:179-84. Prog Clin Biol Res. 1991. PMID: 1924448 No abstract available.

6

Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer.

Priolo G, Gontero P, Martinasso G, Mengozzi G, Formiconi A, Pelucelli G, Zitella A, Casetta G, Viberti L, Aimo G, Tizzani A. Priolo G, et al. Among authors: tizzani a. Clin Chim Acta. 2001 Mar;305(1-2):47-53. doi: 10.1016/s0009-8981(00)00416-2. Clin Chim Acta. 2001. PMID: 11249922

7

DNA flow cytometry and 67Ki proliferating index as prognostic factors of early recurrence and progression in G1-G2/Ta-T1 and G3/Ta-T1 transitional cell carcinoma of the bladder.

Tizzani A, Casetta G, Gontero P, Giammò A, Ghabin H, Demurtas S, Pacchioni D. Tizzani A, et al. Minerva Urol Nefrol. 1997 Sep;49(3):141-3. Minerva Urol Nefrol. 1997. PMID: 9396221

8

[Aztreonam in complicated infections of the urinary tract].

Tizzani A, Casetta G, Piana P. Tizzani A, et al. Minerva Urol Nefrol. 1986 Jul-Sep;38(3):263-5. Minerva Urol Nefrol. 1986. PMID: 3810387 Italian. No abstract available.

9

ERCC1 haplotypes modify bladder cancer risk: a case-control study.

Ricceri F, Guarrera S, Sacerdote C, Polidoro S, Allione A, Fontana D, Destefanis P, Tizzani A, Casetta G, Cucchiarale G, Vineis P, Matullo G. Ricceri F, et al. Among authors: tizzani a. DNA Repair (Amst). 2010 Feb 4;9(2):191-200. doi: 10.1016/j.dnarep.2009.12.002. Epub 2010 Jan 12. DNA Repair (Amst). 2010. PMID: 20061190

10

Bladder pheochromocytoma: a 3-year follow-up after transurethral resection (TURB).

Baima C, Casetta G, Vella R, Tizzani A. Baima C, et al. Among authors: tizzani a. Urol Int. 2000;65(3):176-8. doi: 10.1159/000064868. Urol Int. 2000. PMID: 11054040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters